Generic antiepileptic drug prescribing: A cross-sectional study

Jennifer Meyer; David Fardo; Steven T. Fleming; Claudia Hopenhayn; Yevgeniya Gokun; Melody Ryan

doi:10.1016/j.yebeh.2012.10.010

Generic antiepileptic drug prescribing: A cross-sectional study

Jennifer Meyer
, David Fardo
, Steven T. Fleming
, Claudia Hopenhayn
, Yevgeniya Gokun
, Melody Ryan

Producción científica: Article › revisión exhaustiva

9 Citas (Scopus)

Resumen

The use of generic antiepileptic drugs (AEDs) in patients with epilepsy is controversial. The purpose of this study is to identify patient characteristics associated with increased odds of receiving a generic AED product. A large commercial database was used to identify patients with a primary diagnosis of epilepsy who were prescribed an AED during a three-month window. Data analysis found that those ≥ 65. years old had 15.7% greater odds of receiving a generic AED (OR = 1.157; 95% CI = 1.056-1.268). Patients with Medicaid were found to have 2.44 times the odds of having had a generic AED prescription (OR = 2.44; CI = 2.168-2.754). Patients residing in the Northeast had 12.6% decreased odds of receiving a generic AED (OR = 0.874; CI = 0.821-0.931). These patient characteristics could signify certain health care disparities and may represent potential confounders to future observational studies.

Idioma original	English
Páginas (desde-hasta)	1-6
Número de páginas	6
Publicación	Epilepsy and Behavior
Volumen	26
N.º	1
DOI	https://doi.org/10.1016/j.yebeh.2012.10.010
Estado	Published - ene 2013

Nota bibliográfica

Funding Information:
The project described was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health through Grant UL1RR033173 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Financiación

The project described was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health through Grant UL1RR033173 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Financiadores	Número del financiador
National Institutes of Health (NIH)
National Center for Research Resources	UL1RR033173
National Center for Research Resources
National Center for Advancing Translational Sciences (NCATS)	UL1TR001998
National Center for Advancing Translational Sciences (NCATS)

ASJC Scopus subject areas

Neurology
Clinical Neurology
Behavioral Neuroscience

Acceder al documento

10.1016/j.yebeh.2012.10.010

Otros archivos y enlaces

Citar esto

@article{63718f16000e4486929cc37ad6271c59,

title = "Generic antiepileptic drug prescribing: A cross-sectional study",

abstract = "The use of generic antiepileptic drugs (AEDs) in patients with epilepsy is controversial. The purpose of this study is to identify patient characteristics associated with increased odds of receiving a generic AED product. A large commercial database was used to identify patients with a primary diagnosis of epilepsy who were prescribed an AED during a three-month window. Data analysis found that those ≥ 65. years old had 15.7\% greater odds of receiving a generic AED (OR = 1.157; 95\% CI = 1.056-1.268). Patients with Medicaid were found to have 2.44 times the odds of having had a generic AED prescription (OR = 2.44; CI = 2.168-2.754). Patients residing in the Northeast had 12.6\% decreased odds of receiving a generic AED (OR = 0.874; CI = 0.821-0.931). These patient characteristics could signify certain health care disparities and may represent potential confounders to future observational studies.",

keywords = "Antiepileptic drugs, Cross-sectional, Epilepsy, Generic drugs, Prescribing",

author = "Jennifer Meyer and David Fardo and Fleming, \{Steven T.\} and Claudia Hopenhayn and Yevgeniya Gokun and Melody Ryan",

note = "Funding Information: The project described was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health through Grant UL1RR033173 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. ",

year = "2013",

month = jan,

doi = "10.1016/j.yebeh.2012.10.010",

language = "English",

volume = "26",

pages = "1--6",

number = "1",

}

TY - JOUR

T1 - Generic antiepileptic drug prescribing

T2 - A cross-sectional study

AU - Meyer, Jennifer

AU - Fardo, David

AU - Fleming, Steven T.

AU - Hopenhayn, Claudia

AU - Gokun, Yevgeniya

AU - Ryan, Melody

N1 - Funding Information: The project described was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health through Grant UL1RR033173 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

PY - 2013/1

Y1 - 2013/1

N2 - The use of generic antiepileptic drugs (AEDs) in patients with epilepsy is controversial. The purpose of this study is to identify patient characteristics associated with increased odds of receiving a generic AED product. A large commercial database was used to identify patients with a primary diagnosis of epilepsy who were prescribed an AED during a three-month window. Data analysis found that those ≥ 65. years old had 15.7% greater odds of receiving a generic AED (OR = 1.157; 95% CI = 1.056-1.268). Patients with Medicaid were found to have 2.44 times the odds of having had a generic AED prescription (OR = 2.44; CI = 2.168-2.754). Patients residing in the Northeast had 12.6% decreased odds of receiving a generic AED (OR = 0.874; CI = 0.821-0.931). These patient characteristics could signify certain health care disparities and may represent potential confounders to future observational studies.

AB - The use of generic antiepileptic drugs (AEDs) in patients with epilepsy is controversial. The purpose of this study is to identify patient characteristics associated with increased odds of receiving a generic AED product. A large commercial database was used to identify patients with a primary diagnosis of epilepsy who were prescribed an AED during a three-month window. Data analysis found that those ≥ 65. years old had 15.7% greater odds of receiving a generic AED (OR = 1.157; 95% CI = 1.056-1.268). Patients with Medicaid were found to have 2.44 times the odds of having had a generic AED prescription (OR = 2.44; CI = 2.168-2.754). Patients residing in the Northeast had 12.6% decreased odds of receiving a generic AED (OR = 0.874; CI = 0.821-0.931). These patient characteristics could signify certain health care disparities and may represent potential confounders to future observational studies.

KW - Antiepileptic drugs

KW - Cross-sectional

KW - Epilepsy

KW - Generic drugs

KW - Prescribing

UR - https://www.scopus.com/pages/publications/84870337960

UR - https://www.scopus.com/pages/publications/84870337960#tab=citedBy

U2 - 10.1016/j.yebeh.2012.10.010

DO - 10.1016/j.yebeh.2012.10.010

M3 - Article

C2 - 23182806

AN - SCOPUS:84870337960

SN - 1525-5050

VL - 26

SP - 1

EP - 6

JO - Epilepsy and Behavior

JF - Epilepsy and Behavior

IS - 1

ER -

Generic antiepileptic drug prescribing: A cross-sectional study

Resumen

Nota bibliográfica

Financiación

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto